COVID-19, scientific philosophy, left main coronary artery
disease, empagliflozin and the SGLT2 inhibitors are the topics
discussed by John Mandrola, MD in this week’s podcast
This podcast delivers Dr. John Mandrola’s summary and perspective on top news of the week that cardiologists can’t miss. This podcast is intended for US health professionals only.